Market Place
Sourcing Support
Veloxis Selected For Presentation At ATC 2024 In Philadelphia
30 May 2024 //
PR NEWSWIRE
Lyfebulb & Veloxis Announce Finalists for Challenge in Organ Transplantation
19 Sep 2022 //
PRNEWSWIRE
Veloxis Pharma Announces Dosing by partner Xenikos in PIII Study of T-Guard
28 Jun 2022 //
PRNEWSWIRE
Veloxis Pharma Begins Dosing in PI Study of VEL-101
18 May 2022 //
PRNEWSWIRE
Veloxis Pharmaceuticals Obtains FDA FTD for CD28 Antagonist VEL-101/FR104
17 Feb 2022 //
GLOBENEWSWIRE
OSE and Veloxis Enter Into Global License Agreement to Develop, Manufacture
26 Apr 2021 //
PRNEWSWIRE
Athena Licenses Veloxis’ Lipid-Lowering Drug AtorFen for Emerging Markets
23 Dec 2011 //
GENENG NEWS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.